SpringWorks Therapeutics, Inc. (SWTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 3.07B |
| Enterprise value | 2.64B |
| Trailing P/E | 21.09 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 103.42 |
| Price/book (mrq) | 5.41 |
| Enterprise value/revenue | 99.86 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 0.84 |
| 52-week change 3 | 55.63% |
| S&P500 52-week change 3 | 23.49% |
| 52-week high 3 | 53.92 |
| 52-week low 3 | 18.00 |
| 50-day moving average 3 | 44.57 |
| 200-day moving average 3 | 36.23 |
Share statistics
| Avg vol (3-month) 3 | 872.89k |
| Avg vol (10-day) 3 | 703.35k |
| Shares outstanding 5 | 74.09M |
| Implied shares outstanding 6 | 74.09M |
| Float 8 | 72.45M |
| % held by insiders 1 | 2.27% |
| % held by institutions 1 | 109.98% |
| Shares short (15 May 2024) 4 | 10.69M |
| Short ratio (15 May 2024) 4 | 11.47 |
| Short % of float (15 May 2024) 4 | 17.48% |
| Short % of shares outstanding (15 May 2024) 4 | 14.44% |
| Shares short (prior month 15 Apr 2024) 4 | 10.54M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -447.16% |
Management effectiveness
| Return on assets (ttm) | -36.63% |
| Return on equity (ttm) | -63.12% |
Income statement
| Revenue (ttm) | 26.45M |
| Revenue per share (ttm) | 0.40 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -357.1M |
| Net income avi to common (ttm) | -339.07M |
| Diluted EPS (ttm) | -5.15 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 436.58M |
| Total cash per share (mrq) | 5.9 |
| Total debt (mrq) | 6.56M |
| Total debt/equity (mrq) | 1.16% |
| Current ratio (mrq) | 6.85 |
| Book value per share (mrq) | 7.67 |
Cash flow statement
| Operating cash flow (ttm) | -239.91M |
| Levered free cash flow (ttm) | -120.9M |
© 2024 Yahoo. All rights reserved.